Evaluating a new tissue glue for catheter insertion sites
Evaluation of a Tissue Glue SecurePortIV on Prevention of Phlebitis and Migration of PICC and Midline Catheters in Adult Patients
NA · University Hospital Ostrava · NCT04900740
This study is testing a new tissue glue to see if it can help prevent problems at the insertion sites of catheters in adults compared to standard care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Ostrava (other) |
| Locations | 1 site (Ostrava, Moravian-Silesian Region) |
| Trial ID | NCT04900740 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a cyanoacrylate tissue glue called Secure PortIV on the insertion sites of peripherally inserted central catheters (PICC) and midline catheters. A total of 250 adult participants will be enrolled, with half receiving the tissue glue and the other half receiving standard care. The study will assess the incidence of mechanical and infective phlebitis, as well as catheter migration, through evaluations conducted on the first and seventh days post-insertion. The goal is to determine if the tissue glue can improve patient outcomes related to catheter use.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who require long-term venous access.
Not a fit: Patients who are pediatric or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce complications associated with catheter use, improving patient safety and comfort.
How similar studies have performed: While the use of tissue glue in catheter fixation is a novel approach, similar studies have shown promising results in reducing complications.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age * need of long-term venous access * consent with participation in the study Exclusion Criteria: * pediatric population * not signing the informed consent form
Where this trial is running
Ostrava, Moravian-Silesian Region
- University Hospital Ostrava — Ostrava, Moravian-Silesian Region, Czechia (RECRUITING)
Study contacts
- Principal investigator: Iveta Constantine, Bc., MSc. — University Hospital Ostrava
- Study coordinator: Jiří Hynčica
- Email: jiri.hyncica@fno.cz
- Phone: 0042059737
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Adult Patients With Mid-term or Long-term Venous Access, peripherally inserted central catheter, midline, cyanoacrylate tissue glue, tissue glue, phlebitis, catheter migration